PMID: 8949426Sep 1, 1996Paper

Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis

The British Journal of Dermatology
H M LewisL Fry

Abstract

A retrospective study of 487 patients with dermatitis herpetiformis showed that lymphoma developed in eight patients, the expected incidence being 0.21 (standardized registration ratio 3810). All lymphomas occurred in patients whose dermatitis herpetiformis had been controlled without a gluten-free diet (GFD) or in those who had been treated with a GFD for less than 5 years. The results are suggestive of a protective role for a GFD against lymphoma in dermatitis herpetiformis and give further support for advising patients to adhere to a strict GFD for life.

References

Sep 25, 1976·British Medical Journal·J M Fowler, D J Thomas
Sep 28, 1985·Lancet·P G IsaacsonD Y Mason
Feb 6, 1988·Lancet·A G StansfeldO Mioduszewska
Oct 1, 1974·Journal of Clinical Pathology·L FryR M McMinn
May 1, 1972·British Journal of Preventive & Social Medicine·I D Hill
Oct 30, 1982·Lancet·D J Gawkrodger, R S Barnetson
Jan 1, 1983·British Medical Journal·J N LeonardL Fry
Sep 1, 1983·Clinical and Experimental Dermatology·D B BuckleyM J Whelton
Mar 1, 1984·Journal of the American Academy of Dermatology·T ReunalaH Helin
Dec 1, 1982·The British Journal of Dermatology·L FryR M McMinn
Aug 1, 1993·The British Journal of Dermatology·A J SwerdlowJ S English
Sep 1, 1994·Gut·P CollinA Pasternack
Jan 1, 1994·BMJ : British Medical Journal·B SigurgeirssonB Lindelöf

❮ Previous
Next ❯

Citations

Jan 27, 2007·Digestive Diseases and Sciences·M AbuzakoukC Feighery
Mar 17, 2012·Journal of Gastrointestinal Cancer·Justin HartkeSalma Akram
Jun 14, 1997·Lancet·M Mäki, P Collin
Jun 28, 2001·Clinical and Experimental Dermatology·W M PorterC B Bunker
Apr 16, 2002·Journal of the European Academy of Dermatology and Venereology : JEADV·M DelfinoC Ciacci
Jan 20, 2005·The British Journal of Dermatology·K HervonenT Reunala
Jun 15, 2005·Journal of Paediatrics and Child Health·Daniel LembergTimothy Bohane
Mar 14, 2007·BMC Gastroenterology·Marco SilanoUNKNOWN Collaborating centers of the Italian registry of the complications of coeliac disease
Sep 16, 2006·Blood·Thorvardur R HalfdanarsonJoseph A Murray
Nov 14, 2006·Postgraduate Medical Journal·C J R Goddard, H R Gillett
Oct 29, 2013·Clinics in Dermatology·Nikita LakdawalaJane M Grant-Kels
Jan 16, 2013·Journal of the American Academy of Dermatology·Breck ThrashAlan Menter
May 9, 2012·Immunology and Allergy Clinics of North America·Adela Rambi G Cardones, Russell P Hall
Sep 20, 2011·Dermatologic Clinics·Adela Rambi G Cardones, Russell P Hall
Jul 27, 1999·The Journal of Investigative Dermatology·W DieterichD Schuppan
May 17, 2011·Journal of the American Academy of Dermatology·Diana Bolotin, Vesna Petronic-Rosic
May 17, 2011·Journal of the American Academy of Dermatology·Diana Bolotin, Vesna Petronic-Rosic
Mar 15, 2011·Annales de dermatologie et de vénéréologie·S Ingen-Housz-Oro
Nov 3, 2010·Clinics in Dermatology·Flavia FedelesJane M Grant-Kels
Sep 14, 2010·La Presse médicale·Bertrand LiogerLaurent Machet
Feb 27, 2007·Current Problems in Pediatric and Adolescent Health Care·M Luisa Mearin
Apr 6, 2005·Clinical and Experimental Dermatology·T Hamada, T Hashimoto
May 28, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·M CaproniUNKNOWN Italian Group for Cutaneous Immunopathology
Mar 5, 2008·Alimentary Pharmacology & Therapeutics·N R LewisJ West
Sep 8, 2007·International Journal of Dermatology·Javier Alonso-LlamazaresRoy S Rogers
Jun 20, 2012·The British Journal of Dermatology·K HervonenT Reunala
Feb 5, 2005·Journal of the American Academy of Dermatology·Peter C Schalock, Richard D Baughman
Sep 16, 2000·The Journal of Dermatology·Y AmoK Katsuoka
Jun 12, 2014·Gut·Jonas F LudvigssonUNKNOWN British Society of Gastroenterology
May 23, 2012·Clinical & Developmental Immunology·Anna AlakoskiPekka Collin
May 17, 2019·Clinical and Experimental Dermatology·T T Salmi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.